Lifestyle factors and chronic pathological states are important contributors to inter-individual variability in susceptibility to xenobiotic-induced toxicity. Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent condition that can dramatically affect chemical metabolism. We examined the effect of NAFLD on toxicokinetics of tetrachloroethylene (PERC), a ubiquitous environmental contaminant that requires metabolic activation to induce adverse health effects. Mice (C57Bl/6J, male) were fed a low-fat diet (LFD), high fat diet (HFD), or methionine/folate/choline-deficient diet (MCD) to model a healthy liver, steatosis, or nonalcoholic steatohepatitis (NASH), respectively. After 8 weeks, mice were orally administered a single dose of PERC (300 mg/kg) or vehicle (aqueous Alkamuls-EL620) and sacrificed at various time points (1-36 hours). Levels of PERC and its metabolites were measured in blood/serum, liver, and fat. Effects of diets on liver gene expression and tissue:air partition coefficients were evaluated. We found that hepatic levels of PERC were 6-and 7.6-fold higher in HFD-and MCD-fed mice compared to LFD-fed mice; this was associated with an increased PERC liver:blood partition coefficient. Liver and serum C max for trichloroacetate (TCA) was lower in MCD-fed mice, however hepatic clearance of TCA was profoundly reduced by HFD or MCD feeding, leading to TCA accumulation. Hepatic mRNA/protein expression and ex vivo activity assays revealed decreased xenobiotic metabolism in HFD-and MCD-, compared to LFD-fed, groups. In conclusion, experimental NAFLD was associated with modulation of xenobiotic disposition and metabolism, and increased hepatic exposure to PERC and TCA.
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Introduction
Inter-individual variability is a major challenge for the assessment of human health burden associated with exposure to environmental contaminants (Zeise et al., 2013) . Variability in toxicokinetics and ensuing metabolic activation of the parent chemical to relatively more toxic metabolites is often the underlying cause of the variability in adverse health responses (Bois et al., 2010) . The role of genetic factors in the population variability in drug and chemical metabolism is well established (Relling and Evans, 2015) ; however, a variety of other factors such as sex, age, diet, and underlying disease states may also contribute to inter-individual variability. Specifically, non-alcoholic fatty liver disease (NAFLD) is a growing public health burden, with a global prevalence of ~25% (Younossi et al., 2016b) and an associated economic impact that may exceed US$900 billion over the next 10 years in the U.S. alone (Younossi et al., 2016a) . NAFLD encompasses two clinically distinct disease states, simple steatosis and the more severe non-alcoholic steatohepatitis (NASH). Experimental and human NAFLD has been shown to be associated with dysregulation in pharmaco-/toxico-kinetics of a variety of chemicals, including pharmaceutical and environmental chemicals (Buechler and Weiss, 2011; Merrell and Cherrington, 2011; Naik et al., 2013; Clarke and Cherrington, 2015 ).
An excellent case study substance to examine the role of NAFLD as a susceptibility factor in chemical-induced adverse health effects is tetrachloroethylene (perchloroethylene; PERC). It was recently shown that genetics is a major, but not the only, determinant of interindividual variability in toxicokinetics of PERC [(Cichocki et al., 2016a) , in press]. The U.S.
Environmental Protection Agency (EPA) in its Toxicological Review of PERC stated that preexisting disease status may contribute to variation in response to PERC through alteration of JPET #238790 5 toxicokinetics of PERC and its metabolites; however, there are few studies on the contribution of disease states to PERC toxicokinetics (U.S. EPA, 2011).
PERC is a high-production volume chlorinated olefin solvent, with industrial uses in drycleaning, metal degreasing, and as a chemical feedstock (Cichocki et al., 2016b) . Due to its widespread use, high production volume and persistence in the environment, PERC has become a ubiquitous environmental contaminant of ambient air, soil, and drinking and ground water, and is one of the most commonly found contaminants at hazardous waste sites (National Research Council, 2010) . Exposure to PERC in humans and animals is associated with multiple target organ toxicity, including both cancer and non-cancer toxicity (U.S. EPA, 2011; Guha et al., 2012; IARC, 2013; Guyton et al., 2014; Cichocki et al., 2016b) . In mice, hepatotoxicity associated with PERC exposure is thought to be mediated by trichloroacetate (TCA), an oxidative metabolite of PERC (Bull et al., 1990; Bull, 2000; Corton, 2008) . Indeed, hepatic oxidative metabolism of PERC was the primary dose metric chosen by the U.S. EPA to derive an oral reference dose/concentration for the carcinogenic risk of PERC (U.S. EPA, 2011); thus, the toxicokinetics of PERC and TCA are important considerations when establishing concentrationresponse relationships.
Although PERC has been studied for decades, very little is known about the specific enzyme(s) involved in PERC metabolism, especially under chronic disease conditions that may have a profound impact on metabolic capacity. It is known that PERC is metabolized by human and rodent hepatic cytochrome P450s (CYPs) to TCA (Cichocki et al., 2016b) . Additionally, PERC can also be conjugated with glutathione through glutathione S-transferases (GSTs) to form S-(1,2,2-trichlorovinyl)-glutathione (TCVG). TCVG can be converted in the kidney through a two-step metabolic reaction to yield S-(1,2,2-trichlorovinyl)-L-cysteine (TCVC). TCVC is a JPET #238790 6 metabolite of high concern as it can be converted to cytotoxic and genotoxic electrophiles (Vamvakas et al., 1987; Vamvakas et al., 1988; Vamvakas et al., 1989; Irving and Elfarra, 2013) and can be detoxified to the mercapturate N-Acetyl-S-(1,2,2-trichlorvinyl)-L-cysteine (NAcTCVC), which is a urinary metabolite of PERC in humans . However, little is known about the effects of NAFLD on these PERC metabolism pathways.
The objective of this study was to examine the toxicokinetics of PERC and its major metabolites in tissues from mice with varying stages of NAFLD. Concentration-time profiles were generated for PERC, TCA, TCVG, TCVC, and NAcTCVC in liver and serum. To identify mechanisms of NAFLD-associated effects on PERC toxicokinetics, mRNA sequencing and other biochemical techniques were employed.
Materials and Methods
Chemicals. PERC (CAS 127-18-4) was purchased from Sigma Aldrich (Cat No. 270393, Batch No. SHBD9374V, purity 99.93%; St. Louis, MO). Analytical standards for S-(1,2,2-trichlorovinyl) glutathione (TCVG), Carolina, Chapel Hill. Purity of all standards was determined to be >95% by NMR and mass spectroscopy. All other chemicals were of the highest purity available and were acquired from commercial vendors.
Animals. Five-week old male C57Bl/6J mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and housed in polycarbonate cages with Sanichip hardwood chip bedding (P.J.
Murphy Forest Products Corp., Montville, NJ). Mice were acclimatized for at least one week on (Tryndyak et al., 2012) , which is a common deficiency of other MCD diets (Maher, 2011) .
Study Design. Following eight weeks of dietary treatments as detailed above, mice were administered a single intragastric dose of PERC (300 mg/kg in 5% Alkamuls-EL620 in saline).
This dose was selected as the toxicokinetics of PERC and TCA in male mice after exposure to 150-1000 mg/kg PERC has been characterized in liver and blood (Philip et al., 2007) and was shown to be well-tolerated in acute (Philip et al., 2007) and sub-chronic studies (National Toxicology Program, 1977) . Mice (n=5/diet/time-point) were euthanized at 1, 2, 4, 12, or 24 hours after gavage (total n=75). In addition, 4 mice per diet group were individually placed in stainless steel metabolic cages with wire mesh bottoms (Techniplast, Chester, PA) for 36 hours for urine collection (total n=12). Five mice per diet were treated with vehicle and euthanized at 24 hours post gavage to perform additional biochemical analyses (total n=15). At the respected time points, animals were deeply anesthetized with pentobarbital (50 mg/kg, i.p.) and sacrificed via exsanguination through the vena cava, which was the site of blood collection. or serum (50 µL) were subjected to solid-phase extraction prior to separation and detection via LC/MS-MS. Calibration curves were prepared in blank tissue from C57Bl/6J mice which were subjected to the same extraction process. The concentration of analyte was determined by taking the response ratio of the analyte to the isotopically-labeled internal standard.
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Partition Coefficients. Blood:air and liver:blood partition coefficients were performed using a vial equilibration method (Morris and Cavanagh, 1986 reads were sequenced using an Illumina HiSeq 2500 instrument on 8 sequencing lanes; all samples were run on the same flow cell. A total of 1.83 billion reads were checked to trim any adapter sequences and low quality bases using Trimmomatic (Bolger et al., 2014) resulting in 1.79 billion filtered reads (98%) out of which a total of 1.74 billion filtered reads (approximately 97%) mapped to the GRcm38/mm10 assembly. Read mapping was performed using TopHat version 2.0.13 (Trapnell et al., 2009) . HTSeq (Anders et al., 2015) was used to generate raw read counts per gene using the intersection-nonempty parameter to account for ambiguous read mappings.
Differential gene expression tests were then performed via the R (v 3.3.1) package DESeq2 (v 1.12.3) (Love et al., 2014) on the complete list of 18,239 genes after removing low count genes, following recommended guidelines by the authors. Normalized mRNA counts used for data analysis were an output from the DESeq2, which uses an internal normalization algorithm. Briefly, for each gene, a size factor is estimated by calculating the quotient of the raw counts in each sample divided by the raw counts of the geometric mean (all samples), which is effectively a sequencing depth ratio for each gene. The median of all of these quotients is then the relative sequencing depth of the library. This effect size is used to normalize all of the counts of each gene across all of the samples that were sequenced. To be deemed differentiallyexpressed, log2 fold-changes (compared to LFD group) and false discovery rate (FDR)-adjusted p-values were cut off at 0.58 and 0.1, respectively. A cut-off for log2 of 0.58 represents an approximate 1.5-fold change in expression level compared to the reference (LFD) group. Default settings in DESeq2 were used for FDR adjustment (Benjamini and Hochberg, 1995) . One sample from the HFD group was identified as a technical outlier and was therefore removed from further analysis.
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JPET Fast Forward. The resulting gene expression values were used for biological pathway analysis using the "piano" (Varemo et al., 2013) package in R (package v 1.12.0) in conjunction with the "Mouse Reactome" gene set (retrieved from www.baderlab.org on November 11 th , 2016). For analysis of xenobiotic-metabolizing enzymes, genes with the starting combination of letters "Abc", "Slc", "Gst", "Cyp", "Ugt", "Sult", "Nat", "Ces", "Aldh", and "Adh" were selected from the complete list of mapped genes. A total of 618 genes were retrieved and validated as belonging to these families. Visuals of differentially-expressed genes and enriched pathways were generated in R.
Western blotting. Liver whole tissue lysates were prepared using a commercially-available S9 fraction activity assays. This method was adapted from a previously established method (Lash et al., 2007) . Liver tissue (100 mg) was homogenized in 4 volumes of ice-cold buffer (0.1M potassium phosphate buffer containing 0.5 mM ethylenediaminetetraacetic acid, pH 7.4) using a bead ruptor (see above). Homogenates were centrifuged (9,000g, 20 min, 4 o C), and supernatants were aliquoted into equal volumes. Samples were kept on ice until used (typically within one hour). 100 µL of homogenate was added to a 2 mL glass amber vial containing 400 µL of buffer determined and associated p-values were corrected for multiple comparisons (Benjamini and Hochberg, 1995) to derive q-values using standard R computing. For transcript abundance, normalized mRNA counts (via estimating gene-level size factors) from DESeq2 were used.
Details on the algorithm used by this R package can be found in (Love et al., 2014) .
JPET Fast Forward. Figure 1) . In addition to liver histopathology, body weight, body composition, liver-and fat-to-body weight ratios, serum ALT, and serum and liver triglycerides were measured to further characterize the underlying liver disease states in this study (Table 1) . Overall, these data confirmed that animals in this study exhibited desirable NAFLD disease phenotypes, which included steatosis or NASH. MCD-fed animals in this study did not exhibit loss of body weight or body fat content.
Effect of NAFLD on PERC toxicokinetics. The toxicokinetics of PERC in blood, liver, and gonadal adipose tissue varied considerably following a single intragastric dose (300 mg/kg) depending on the liver disease state (Figure 1 ). (Gargas et al., 1989; Gearhart et al., 1993) . To determine whether lipid content of the blood, which may affect the partition coefficient, was different between groups, serum triglyceride levels were measured (Table 1) . Serum triglyceride levels were similar between groups. Conversely, the liver:air partition coefficients were varying based on the underlying liver disease state ( Figure 2B ). Specifically, the liver:air partition coefficients were 61.3±4.9, 149±50.6, and 300±78.9 for LFD-, HFD-, and MCD-fed mice, respectively, with Hepatic levels of TCVG, TCVC, and NAcTCVC were lower in HFD-or MCD-fed mice as compared to LFD-fed mice; this was particularly noticeable for TCVG, where hepatic AUCs in HFD-or MCD-fed mice were ~3-fold lower as compared to LFD-fed mice (Table 2) have examined differential expression of the genes in Cyp, Gst, Abc transporter, and Slc/Slco transporter families due to their potential contribution to PERC metabolism. As reported previously , we found that most CYPs, except for the Cyp4a family involved in lipid metabolism, were down regulated by experimental NAFLD (Figure 6 ). Multiple GSTs were also repressed, with Gsta1 being the only exception in MCD-fed mice.
Interestingly, levels of multiple GSTs were increased in MCD-fed mice as compared to HFD-fed mice. The pattern of xenobiotic transporter expression was diet-dependent. We observed that the number of differentially-expressed xenobiotic transporters were higher in MCD-fed mice compared to HFD-fed mice. Further, in both HFD-and MCD-fed mice, there were more transporters which were up-regulated compared to down-regulated. Expression of Slc35f2 and Slc13a2 were notably higher and lower, respectively, in HFD-and MCD-fed mice compared to LFD-fed controls. We did not observe any xenobiotic efflux transporter genes which decreased in expression in both HFD-and MCD-fed mice. Further, we did not observe any xenobiotic uptake transporter genes which increased in expression in both HFD-and MCDfed mice.
Next, we performed a correlation analysis among differentially expressed metabolism genes and PERC and TCA pharmacokinetic parameters. We found that 17 CYP450 genes were significantly negatively-correlated with hepatic PERC AUC and positively-correlated with TCA levels at 4 hours (Pearson's r>|0.70|, q<0.05; Supplementary Table 1 ). The 4-hour time point was chosen because TCA levels differed among the three groups at this time point. Of particular interest (Supplementary Figure 3, Figure 7 ) were the highly-expressed Cyp2c29 and Cyp3a11 genes, along with Cyp2b10, the mouse orthologue of CYP2B6, which was shown to metabolize PERC (White et al., 2001) . No CYP450 genes were identified that correlated with hepatic TCA To determine whether the observed changes in Cyp2c29, Cyp3a11, and Cyp2b10 mRNA expression were associated with changes in protein expression and activity, we performed western blotting and ex vivo activity assays using hepatic S9 fractions. These results, along with the mRNA results, are displayed in Figure 7 . Although not statistically-significant among the different diet groups (p=0.137, ANOVA), the formation of TCA from PERC in hepatic S9
incubations was almost two-fold greater in LFD-fed mice as compared to HFD-or MCD-fed mice. TCA formation (nmol/min/g liver) in LFD-, HFD-and MCD-fed mice was 0.781±0.179, 0.352±0.109, and 0.392±0.153 (mean±SEM), respectively. The hepatic protein expression of CYP3A and CYP2B10 was significantly decreased by approximately 40-50% in HFD-or MCDfed mice compared to LFD-fed mice, which agreed with our mRNA data. CYP2C29 expression was decreased in HFD-and MCD-fed mice by about 20% compared to LFD-fed controls, however this was not a statistically-significant finding (p=0.081, ANOVA).
Discussion
We have previously shown that inter-individual variability in toxicokinetics of PERC varies significantly across a population of inbred mice [(Cichocki et al., 2016a) , in press]. In this study, PERC was used as a model toxicant to investigate the contribution of underlying NAFLD to inter-individual variability in toxicokinetics of environmental chemicals. PERC is an ideal case-study chemical as its metabolism is proposed to play a critical role in its mode of toxicity, and thus alteration of metabolism will likely alter PERC-associated adverse health effects.
NAFLD carries significant public health and economic burden (Younossi et al., 2016a; Younossi et al., 2016b) . Experimental NAFLD has been shown to alter the metabolism of a variety of different xenobiotics (Buechler and Weiss, 2011; Merrell and Cherrington, 2011; Naik et al., 2013; Clarke and Cherrington, 2015) , including environmental chemicals (Canet et al., 2012) , which can have a consequence on pharmaco-and toxico-dynamics Dzierlenga et al., 2015) . However, a detailed examination of the effects of NAFLD on toxicokinetics of an environmental chemical and its metabolites in multiple tissues has not yet been reported. As delivered dose of both PERC and its major metabolites may contribute to target organ-specific toxicity (Lash and Parker, 2001; Guyton et al., 2014; Cichocki et al., 2016b) , such an examination is warranted for this ubiquitous environmental contaminant.
PERC is a volatile chlorinated solvent with almost no solubility in water. As such, it is not surprising that it has a high affinity for adipose tissue, as indicated by its high fat:blood partition coefficient of >1,000; (Gargas et al., 1989; Gearhart et al., 1993) . Because there are no data on blood:air and liver:air partitioning of PERC in liver disease models, our data contributes significantly to the understanding of pharmacokinetics of this important environmental chemical in a human population. Here, we demonstrate that fat-laden livers from mice with steatosis or NASH have an increased liver:air and liver:blood partition coefficient relative to healthy mice, indicating that PERC will preferentially adsorb to liver tissue in mice with NAFLD. It is likely that the same pattern will hold true in humans with NAFLD as well.
The observed effects of NAFLD on liver lipid homeostasis and liver:blood partitioning of PERC were associated with significant effects on toxicokinetics of PERC and its metabolites. in blood and multiple tissues was similar among all three diet groups, suggesting that the gut absorption of PERC was unaffected by diet. The increased retention of PERC in the lipids in the liver would likely slow its metabolism and make it temporarily unavailable for oxidation. Indeed, there was lesser TCA in the liver at early time points in mice with NASH compared to healthy mice. Another consequence of increased liver fat content in NAFLD could be a decreased affinity of TCA, a water-soluble chemical that is ionized at physiological pH. Disease statespecific physiologically-based pharmacokinetic modeling that builds upon the current PBPK model for PERC (Chiu and Ginsberg, 2011 ) may potentially be a useful tool in the future to better understand the contribution of these physiological parameters to PERC toxicokinetics in individuals with or without NAFLD. The data from this study will be critical for such modeling.
The decreased expression of multiple CYPs in liver tissue of mice with NASH may also contribute to decreased hepatic oxidative capacity and TCA production. Although PERC is a ubiquitous environmental contaminant and high-production volume chemical, the specific CYPs involved in its metabolism in the liver are largely uncharacterized. Here, we show that in mice with steatosis or NASH, there is a significant decrease in CYP2B10 expression at both the mRNA and protein level. CYP2B10 is the mouse ortholog of human CYP2B6, which has been shown to oxidize PERC in human lymphoblastoid MCL-5 cells (White et al., 2001 ). The potential for CYP2B10 to contribute to PERC metabolism is further supported by strong negative correlation of Cyp2b10 levels with PERC liver AUC and TCA levels at 4 hours post gavage. Similar to the findings with CYP2B10, we also observed decreases in Cyp2c29 and and TCA levels at 4 hours post gavage. Further, Cyp2b10 and Cyp3a11 were two of the top 20 most variably-expressed genes among the three diet groups.
Compared to LFD-fed mice, we observed no significant effect on the capacity for liver tissue derived from HFD-or MCD-fed mice to metabolize PERC to TCA ex vivo. We found that liver tissue from LFD-fed male C57Bl/6J formed 780 pmols of TCA per minute per gram of tissue. Our findings in LFD-fed mice are comparable with the previously reported values of 421 pmols of PERC/min/g liver being metabolized to water-soluble metabolites (Reitz et al., 1996) , although strain differences (C57Bl/6J vs. B6C3F1) and substrate concentration (2.5 mM vs.
0.068 mM), and overall extraction and analytical procedures may account for the approximate 2-fold difference. Collectively, our mRNA, protein, and activity data suggest that NAFLDassociated modulation of xenobiotic-metabolizing enzymes contributes to inter-individual variability in PERC metabolism in mice. Furthermore, as PERC is a small lipophilic chemical, it is likely a promiscuous substrate for multiple oxidative enzymes and our data confirm the complexity of the oxidative metabolic pathways for PERC.
The expression of hepatic transporters in experimental NASH has been previously characterized in great detail ). In the current study, a total of 68 genes from the SLC or ABC transporter families were found to be differentially expressed between mice with NAFLD and healthy mice. As PERC is a lipophilic chemical, it does not require xenobiotic transporters to enter the cell. However, TCA will not easily diffuse across the cell membranes and will therefore likely require active transport; however, little is known about specific transporters that may facilitate movement of TCA across membranes in various tissues. We did not find that expression of efflux transporters was negatively-correlated with TCA levels, or that In addition to oxidation, PERC undergoes conjugation via GSTs to form conjugative metabolites which are mutagenic and nephrotoxic (Cichocki et al., 2016b) . However, quantitation of these metabolites has not been previously possible due to their low abundance and quick clearance from tissue and their unsuitability for gas chromatography. We recently developed a LC-MS/MS method with capability to detect 1 pmol of metabolite per gram of tissue, with 50 mg or less of tissue input (Luo et al 2016, submitted manuscript). Here, for the first time, we apply that method to investigate toxicokinetics of TCVG, TCVC, and NAcTCVC in liver and serum of mice exposed to PERC.
From a mass-balance perspective TCVG, TCVC, and NAcTCVC are not significant contributors to PERC metabolism in the mouse, as their peak levels in liver were less than 0.05% of TCA levels, and they were quickly cleared from both liver and serum. These findings are similar to those with trichloroethylene (Yoo et al., 2015) . Interestingly, we found that liver and serum levels of all three GSH conjugation pathway metabolites of PERC were generally reduced in mice with NAFLD compared to healthy mice. This was associated with a decreased expression of a number of genes in the Gst family, which is in agreeance with previously published results showing decreased GST activity from tissue samples from patients with varying stages of NAFLD (Hardwick et al., 2010) . In humans, NAFLD may be associated with an increased risk for chronic kidney disease (Musso et al., 2014; Targher et al., 2014) . As NAFLD may be a risk factor for the development of chronic kidney disease, and as it alters the toxicokinetics of nephrotoxic PERC metabolites, follow up studies on the effects of experimental NAFLD on PERC-associated nephrotoxicity are warranted.
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Our study is not without limitations. First, we only exposed animals to a single dose of PERC, which is fairly high and is not likely to occur in environmental exposure scenarios.
Extrapolating these data to environmentally-relevant exposure levels may be a source of uncertainty (Bois et al., 1996; Bois, 2000; Yang et al., 2006) . Further, as PERC oxidative metabolism is saturable (Buben and O'Flaherty, 1985; Green et al., 1990) , the types of kinetics observed in our study may not be fully representative of what occurs in environmentally-exposed humans. However, in male human volunteers exposed to occupationally-relevant concentrations of PERC (~70-140 ppm, nominal air concentration) via inhalation for 4 hours, ~1% of the absorbed PERC dose was recovered as TCA in the urine (Monster et al., 1979) . This is on the same order of magnitude as observed in our study in mice (~6%, see Table 3 ). In male human volunteers exposed to 1 ppm PERC for 6 hours, recovery of urinary TCA was only ~0.4% of the absorbed PERC dose (Chiu et al., 2007) . Characterization of the effect of NAFLD on PERC toxicokinetics at both low and high concentrations is worthy of further study.
While the dose of PERC used in this study is much greater than expected human exposures, previous reports on humans occupationally-exposed to 50 ppm PERC (nominal air concentration) via inhalation show that urinary levels of NAcTCVC were approximately 0.05% of those of TCA (Birner et al., 1996) , which were similar to what we observed in our study (0.1 %). Our results are dissimilar to those observed in rats and mice exposed to 800 mg/kg PERC via gavage, whereby the urinary level of NAcTCVC was 1-2 % of TCA (Dekant et al., 1986) , which may have been due to differences in administered dose (800 vs 300 mg/kg), strain (NMRI vs C57Bl/6J), sex (female vs. male), vehicle (corn oil vs. aqueous Alkamuls-El 620), or analytical
methodology (GC/MS following derivatization vs. LC-MS/MS).
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While we have made a number of important discoveries about the effect of NAFLD on toxicokinetics of PERC, information that will be of great relevance to human health assessments, we also note that very limited experimental data are available for the toxicological effects of environmental chemicals in subjects with NAFLD. Most of the studies of the effect of NAFLD on xenobiotic metabolism involve drugs, a topic which has been extensively reviewed (Buechler and Weiss, 2011; Merrell and Cherrington, 2011; Naik et al., 2013; Clarke and Cherrington, 2015) . One study examined the effects of NAFLD induced by an MCD diet on hepatotoxicity due to environmental chemical exposure, using a single dose of carbon tetrachloride in rats (Donthamsetty et al., 2007) . Similar to PERC, carbon tetrachloride is a lipophilic chlorinated solvent, with a history of being used as a dry-cleaning solvent until its replacement by PERC in the late 1940s (Doherty, 2000) . Donthamsetty et al. (2007) reported that the sensitivity to carbon tetrachloride-induced hepatotoxicity in rats was not due to differences in metabolism of the parent chemical to a reactive intermediate (based on data from in vivo covalent binding of radiolabeled chemical to hepatic proteins and expression of CYP2E1), but rather that inhibited tissue repair mechanisms in steatotic livers contributed to sensitivity to toxicity. However, the authors did not evaluate levels of parent chemical in liver tissues. As carbon tetrachloride is highly lipophilic, it is conceivable that, similar to our observations with PERC, it would have increased affinity for liver tissue in subjects with NAFLD. Based on the findings of Donthamsetty et al. (2007) , there is potential that NAFLD would contribute to susceptibility to PERC-associated toxicity; thus, follow-up studies of longer duration are needed.
In conclusion, we report for the first time that experimental NAFLD in mice is associated with an increased hepatic deposition of PERC, a lipophilic environmental chemical, and increased hepatic retention of TCA, a hepatotoxic metabolite of PERC. We also report for the 
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